Chloe M.

Chloe M. is an accomplished financial professional currently serving as the Financial Modelling Lead and FP&A Analyst at Rosemont Pharmaceuticals since August 2022, where responsibilities include leading the transition of financial forecasting models to Anaplan. Prior to this, Chloe held the position of Financial Planning and Analysis Manager at Silver Cross Ltd from November 2020 to August 2022, enhancing three-statement financial models, overseeing Power BI migration, and conducting financial analysis across the business. Chloe also served as Management Accountant in the same company, managing month-end processes and providing insights directly to the CFO. Earlier experience includes a role as Corporate Finance Analyst at KPMG, focusing on financial modeling and analysis for transactions, particularly in the technology sector. Chloe holds a Bachelor’s Degree in Economics with French from Durham University and has studied at Aix-Marseille University.